Detection of HPV and ras gene mutations in cervical smears from female genital lesions

Oncology Reports

Volumn 5, Issue 5, 1998, Pages 1195-1198

  Dokianakis, D N ^a   Sourvinos, G ^a   Sakkas, S ^b   Athanasiadou, E ^b   Spandidos, D A ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b GENERAL HOSPITAL OF NIKEA   (Greece)

Author keywords

Genital lesions; HPV; Polymerase chain reaction; Ras genes

Indexed keywords

ARTICLE; FEMALE; GENE MUTATION; HUMAN; ONCOGENE K RAS; ONCOGENE RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS;

EID: 0031858459     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.5.1195     Document Type: Article

References (24)

1. Kiaris H and Spandidos DA: Mutations of ras genes in human tumours (review). Int J Oncol 7: 413-421, 1995.
2. Teneriello MG, Ebina M, Linnoila RI, Henry M, Nash JD, Park RC and Birrer MJ: p53 and Ki-ras gene mutations in epithelial ovarian neoplasmas. Cancer Res 53: 3103-3108, 1993.
3. Spandidos DA (ed): The Super-family of ras related genes. Plenum Press, New York, London, pp1-338, 1991.
4. Enomoto T, Inoue M, Perantoni AO, Buzard GS, Miki H and Tanizawa O: K-ras activation in premalignant and malignant epithelial lesions of the human uterus. Cancer Res 51: 5308-5314, 1991.
5. Trowbridge DI, Risinger JI, Dent GA, Kohler M, Berchuck A, McLachlan JA and Boyd J: Mutations of the Ki-ras oncogene in endometrial carcinoma. Am J Obstet Gynecol 167: 227-232, 1992.
6. Mizuuchi H, Nasim S, Kudo R, Silverberg SG, Greenhouse S and Garrett CT: Clinical implications of K-ras mutations in malignant epithelial tumors of the endometrium. Cancer Res 52: 2777-2781, 1992.
7. Ichikawa Y, Nishida M, Suzuki H, Yoshida S, Tsunoda H, Kubo T, Uchida K and Miwa M: Mutation of K-ras protooncogene is associated with histological subtypes in human mucinous ovarian tumors. Cancer Res 54: 33-35, 1994.
8. Koffa M, Malamou-Mitsi V, Agnantis NJ and Spandidos DA: Mutational activation of K-ras oncogene in human breast tumours. Int J Oncol 4: 573-576, 1994.
9. zur Hausen H: Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta 1288: 55-78, 1996.
10. Hurlin PJ, Kaur P, Smith PP, Perez-Reyes N, Blanton RA and McDougall JK: Progression of human papillomavirus type 18-immortalized human keratinocytes to a malignant phenotype. Proc Natl Acad Sci USA 88: 570-574, 1991.
11. DiPaolo JA, Woodworth CD, Popescu NC, Notario V and Doniger J: Induction of human cervical squamous cell carcinoma by sequential transfection with human papillomavirus 16 DNA and viral Harvey ras. Oncogene 4: 395-399, 1989.
12. Durst M, Gallahan D, Gilbert J and Rhim J-S: Glycocorticoid enhanced neoplastic transformation of human keratinocytes by human papillomavirus type 16 and an activated ras oncogene. Virology 173: 767-771, 1989.
13. Koffa M, Simiakaki H, Ergazaki M, Papaefthimiou M, Karakatsani K, Diakomanolis E and Spandidos DA: HPV detection in stained cytological cervical specimens and correlation with cytology and histology. Oncol Rep 2: 1085-1088, 1995.
14. Spandidos DA, Liloglou T, Arvanitis D and Gourtsoyannis NC: ras gene activation in human small intestinal tumors. Int J Oncol 2: 513-518, 1993.
15. Varras MN, Koffa M, Koumantakis E, Ergazaki M, Protopapa E, Michalas S and Spandidos DA: ras gene mutations in human endometrial carcinoma. Oncology 53: 505-510, 1996.
16. Snijders PJF, van den Brule AJC, Schrijnemakers HFJ, Snow G, Meijer CJLM and Walboomers JMM: The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J Gen Virology 71: 173-181, 1990.
17. Arends MJ, Donaldon YK, Duvall E, Wyllie AM and Bird CC: HPV in full thickness cervical biopsies: high prevalence in CIN2 and CIN3 detected by a sensitive PCR method. J Path 165: 301-309, 1991.
18. Yanez L, Groffen J and Valenzuela DM: c-K-ras mutations in human carcinomas occur preferentially in codon 12. Oncogene 1: 315-318, 1987.
19. Noutsou A, Koffa M, Ergazaki M, Siafakas NM and Spandidos DA: Detection of human papillomavirus (HPV) and K-ras mutations in human lung carcinomas. Int J Oncol 8: 1089-1093, 1996.
20. Riou G, Barrois M, Shenz Z-M, Duvillard P and Lhomme C: Somatic deletions and mutations of c-Ha-ras gene in human cervical cancers. Oncogene 3: 329-333, 1988.
21. Schmauz R, Okong P, de Villiers E-M, Dennin R, Brade L, Lwanga SK and Owor R: Multiple infections in cases of cervical cancer from a high-incidence area in tropical Africa. Int J Cancer 43: 805-809, 1989.
22. Anderson-Ellstrom A, Hagmar BM, Johansson B, Kalantari M, Warleby B and Forssman L: Human papillomavirus deoxyribonucleic acid in cervix only detected in girls after coitus. Int J STD AIDS 7: 333-336, 1996.
23. Koffa M, Koumantakis E, Ergazaki M, Malamou-Mitsi V and Spandidos DA: Detection of ras gene mutations and HPV in lesions of the human female reproductive tract Int J Oncol 5: 189-195, 1994.
24. Kurman RJ, Schiffman MH, Lancaster WD, Reid R, Jenson AB, Temple GF and Lorincz AT: Analysis of individual papillomavirus types in cervical neoplasia: a possible role for type 18 in rapid progression. Am J Obstet Gynecol 159: 293-296, 1988.